Black Breast Cancer serves the needs of black African families whether you are resident in the UK, the US, Europe, Asia or are living on the African continent. We recognise the need to engage with modern medicine and yet to think about alternative forms of prevention and cure in the long-term. In order to combat black breast cancer, we must conceive of ourselves first as the Global African Woman beyond any particular national identity to see the similar global pattern affecting us.

As the Global African Woman, we can come together to find a more effective form of prevention and cure for breast cancer. Currently, the international leading Pink Ribbon Campaign, demonstrates a lack of commitment towards a specific cure for breast cancer. A distinction is made between finding a cure and the development of more drug treatments that ultimately serve the interests of pharmaceutical companies. We reject such a priority and believe a cure for black breast cancer is achievable.

As global African women our breast cancer mortality rates have reached a critical point. For example, in the West, black African women are dying nearly twice as fast as that of white European women. While in sub-Saharan Africa, our mortality rates are twice as high as that in Western Europe. There are improved prognosis for us in the West without evidence of us catching up with white European women. However, breast cancer for our sub-Saharan African sisters is projected to double over the next ten year (BMJ Open, 2016).

Similar to global patterns, breast cancer is the most common cancer in women in sub-Saharan Africa (SSA) (BMJ Open, 2016)

This burden is projected to double between 2012 and 2030 due to population ageing and expansion in Sub-Saharan African.

While breast cancer is, on average, a good-prognosis cancer in high-income countries,
in SSA its prognosis is considerably lower. Excessive deaths due to breast cancer are reflected in a high breast cancer mortality: twice that of Western Europe

Breast cancer death rates are 40% higher among black women than white women. (CDC, US, 2020)

Black women in England are almost twice as likely to be diagnosed with advanced breast cancer as white women, according to a new analysis by Cancer Research UK and Public Health England.

Late-stage disease is found in about 25% of black African and 22% of black Caribbean breast cancer patients.

The mean age at presentation varies between Africa and Europe. It has been reported that the mean age is 48 years in Africa and approximately two-thirds are premenopausal

In the United Kingdom, the median age at presentation for Black women is similar to African women at 46 years compared to 67 years in white British women 

African-American women have also been found to present at a significantly younger age than their Caucasian counterparts